ADAGIO THERAPEUTICS INC's ticker is and the CUSIP is 00534A102. A total of 75 filers reported holding ADAGIO THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is 0.49 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,722,025 | +61.9% | 9,248,250 | 0.0% | 18.03% | +40.5% |
| Q2 2023 | $9,710,663 | -12.5% | 9,248,250 | 0.0% | 12.83% | +2.3% |
| Q1 2023 | $11,097,900 | -20.0% | 9,248,250 | 0.0% | 12.55% | -5.1% |
| Q4 2022 | $13,872,375 | -52.1% | 9,248,250 | 0.0% | 13.22% | -56.2% |
| Q3 2022 | $28,947,000 | +37.9% | 9,248,250 | +44.5% | 30.22% | +28.4% |
| Q2 2022 | $20,986,000 | -28.1% | 6,398,250 | 0.0% | 23.53% | -12.3% |
| Q1 2022 | $29,176,000 | -29.1% | 6,398,250 | +12.9% | 26.83% | -16.5% |
| Q4 2021 | $41,130,000 | – | 5,665,221 | – | 32.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| M28 Capital Management LP | 9,248,250 | $13,872,375 | 13.22% |
| Alphabet Inc. | 5,680,785 | $8,521,178 | 0.50% |
| 683 Capital Management, LLC | 3,000,000 | $4,500,001 | 0.38% |
| Bain Capital Life Sciences Investors, LLC | 1,937,207 | $2,906 | 0.32% |
| Slate Path Capital LP | 3,735,000 | $5,602,500 | 0.30% |
| Newtyn Management, LLC | 900,000 | $1,350,000 | 0.28% |
| Orbimed Advisors | 5,270,400 | $7,905,600 | 0.15% |
| Oasis Management Co Ltd. | 348,432 | $522,648 | 0.10% |
| Redmile Group, LLC | 1,440,725 | $2,161,088 | 0.09% |
| Anson Funds Management LP | 154,156 | $231,234 | 0.04% |